Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-16 · accession 0001805688-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-16 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,637 | 44.6K | +9% | $0 | |
| 2026-01-21 | 2026-01-16 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | F - Tax | $171.16 | -1,599 | 43.0K | -4% | -$273.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-16 | A | A | 3,637 | $0.00 | 44,592 | D | — | — | (F2) The Reporting Person acquired 140 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025. |
| 2 | Common | Ordinary Shares | 2026-01-16 | F | D | 1,599 | $171.16 | 42,993 | D | — | — |